tiprankstipranks
Trending News
More News >
BWX Technologies (BWXT)
NYSE:BWXT

BWX Technologies (BWXT) AI Stock Analysis

Compare
973 Followers

Top Page

BW

BWX Technologies

(NYSE:BWXT)

Rating:76Outperform
Price Target:
$150.00
▲(8.64%Upside)
BWX Technologies scores well due to strong financial performance and positive earnings call highlights, including robust revenue growth and strategic expansions. The primary risk is the high valuation, indicated by a high P/E ratio. Technical analysis suggests caution due to potential overbought conditions.
Positive Factors
Commercial Nuclear Supply Chain
BWX Technologies has a robust position in the commercial nuclear supply chain, especially Canada’s home-grown CANDU reactor fleet.
Domestic Nuclear Fuel Production
BWXT will be a key beneficiary of the focus on domestic nuclear fuel production and quadrupling U.S. nuclear power to 400 GW.
U.S. Navy Nuclear Reactors
BWXT's government division has a monopoly on U.S. Navy nuclear reactors and the fuel that drives them.
Negative Factors
Backlog Below Expectations
BWXT ended 1Q25 with a backlog of $4,878.7M, up 34.2% y/y and 0.7% q/q, below our $6,303.8M estimate.
Commercial Operations Margins
BWXT maintained most 2025 guidance including revenue, EBITDA and FCF, but expects margins in the commercial operations business segment to be at the lower end of the 2025 guidance range.
Regulation and Competition
Risks include regulation, military spending, and competition.

BWX Technologies (BWXT) vs. SPDR S&P 500 ETF (SPY)

BWX Technologies Business Overview & Revenue Model

Company DescriptionBWX Technologies, Inc. (BWXT) is a leading supplier of nuclear components and fuel to the U.S. government. The company operates primarily in the nuclear industry, providing engineering, manufacturing, and management services to support national security and clean energy initiatives. BWXT's core products and services include nuclear reactors, fuel and components for naval nuclear propulsion systems, and medical isotopes for healthcare applications.
How the Company Makes MoneyBWX Technologies makes money through several key revenue streams, primarily driven by government contracts and partnerships. The company is a major supplier of nuclear components and fuel for the U.S. Navy's nuclear-powered submarines and aircraft carriers, which constitutes a significant portion of its revenue. Additionally, BWXT generates income from the production and management of nuclear materials and facilities for various government and commercial clients. The company also capitalizes on its expertise in nuclear technology by providing engineering and technical services for government nuclear programs. Furthermore, BWXT is involved in the development and supply of medical isotopes, contributing to its revenue through sales in the healthcare sector.

BWX Technologies Earnings Call Summary

Earnings Call Date:May 05, 2025
(Q1-2025)
|
% Change Since: 23.55%|
Next Earnings Date:Jul 30, 2025
Earnings Call Sentiment Positive
The earnings call reflects a strong financial performance with significant growth in revenue, adjusted EBITDA, and strategic contract wins. Despite the challenges with raw material costs and delays in Tc-99 approval, the robust bookings, backlog, and strategic expansions in nuclear capabilities contribute to a positive outlook.
Q1-2025 Updates
Positive Updates
Strong Financial Performance
BWXT had a solid start in Q1 2025 with double-digit year-over-year revenue, adjusted EBITDA, and adjusted EPS growth. Revenue was $682 million, up 13%, and adjusted EPS was $0.91, up 20%.
Robust Bookings and Backlog
Commercial operations backlog reached $1.3 billion, up 78% year-over-year, driven by strong bookings in commercial power and nuclear medicine.
Strategic Contract Wins
BWXT won the management and operations contract for the Department of Energy's Strategic Petroleum Reserve and the NNSA's intent to award the Domestic Uranium Enrichment Centrifuge Experiment on a sole-source basis.
Expansion in Nuclear Capabilities
BWXT is expanding the Cambridge manufacturing plant by nearly 50% and progressing with the acquisition of Kinectrics, enhancing its nuclear services portfolio.
Government Operations Growth
Government operations had a strong quarter with 14% revenue growth and 17% adjusted EBITDA growth, driven by naval propulsion and special materials.
Advancements in Nuclear Medicine
BWXT Medical reported double-digit revenue and EBITDA growth, with expectations for full-year revenue growth of over 20%.
Negative Updates
Zirconium Cost Impact
BWXT faced heightened inflation for specialized raw materials in the CANDU Fuel business line, affecting margins. The impact is expected to persist through Q2 but will be mitigated in the second half of the year.
Challenges with Tc-99 Approval
BWXT is still working on perfecting the Tc-99 product for FDA approval, which may extend into early 2026, impacting the 2025 sales outlook.
Company Guidance
During BWX Technologies' first quarter 2025 earnings call, leadership highlighted several key metrics and achievements. The company reported double-digit year-over-year growth in revenue, adjusted EBITDA, and adjusted earnings per share. Specifically, government operations saw a 14% increase in revenue and a 17% rise in adjusted EBITDA, while commercial operations experienced a 10% revenue growth. The commercial operations backlog reached a record $1.3 billion, up 78% from the previous year. The adjusted effective tax rate for the first quarter was 18.3%, contributing to adjusted earnings per share of $0.91, up from $0.76 the previous year. Free cash flow for the quarter was $17 million, with capital expenditures at $33 million, or 4.9% of sales. The company reaffirmed its full-year guidance, expecting mid-single-digit revenue growth in government operations and a 50% increase in commercial operations revenue.

BWX Technologies Financial Statement Overview

Summary
BWX Technologies presents a solid financial outlook with strong revenue growth and stable profitability margins. The company's balance sheet is healthy, marked by consistent equity growth and manageable debt levels. Cash flow from operations is robust, supporting capital investments and enhancing financial flexibility. Attention should be paid to debt trends and capital expenditures.
Income Statement
85
Very Positive
BWX Technologies shows a strong revenue growth trend from 2019 to 2024, with a significant boost in gross profit margin from 2019 to 2024. Key profitability margins, such as EBIT and EBITDA, remain robust, indicating efficient operations. However, a slight dip in net profit margin from 2021 is noted.
Balance Sheet
75
Positive
The company's balance sheet reflects a solid equity position with consistent growth in stockholders' equity. The debt-to-equity ratio shows moderate leverage, which is typical for the industry, but the increasing trend in total debt warrants monitoring. The equity ratio indicates a stable asset base supported by equity.
Cash Flow
80
Positive
BWX Technologies demonstrates strong operating cash flows with substantial growth in free cash flow over recent years. The free cash flow to net income ratio indicates efficient conversion of income into cash, although capital expenditures remain high, impacting net cash flow.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
2.78B2.70B2.50B2.23B2.12B2.12B
Gross Profit
1.19B655.21M620.59M551.93M550.28M575.40M
EBIT
372.75M380.61M383.06M348.57M345.85M358.55M
EBITDA
439.74M474.06M447.00M386.01M470.85M422.34M
Net Income Common Stockholders
289.00M281.94M245.85M238.19M305.87M278.67M
Balance SheetCash, Cash Equivalents and Short-Term Investments
0.0074.11M78.62M39.05M37.70M46.32M
Total Assets
0.002.87B2.75B2.62B2.50B2.29B
Total Debt
1.20B1.06B1.23B1.29B1.19B951.42M
Net Debt
1.20B981.36M1.15B1.25B1.16B908.82M
Total Liabilities
1.95B1.79B1.81B1.87B1.86B1.68B
Stockholders Equity
1.10B1.08B933.35M748.31M637.17M617.77M
Cash FlowFree Cash Flow
269.46M254.78M212.41M46.39M74.97M-58.59M
Operating Cash Flow
426.05M408.43M363.70M244.70M386.03M196.44M
Investing Cash Flow
-280.59M-154.56M-155.64M-256.24M-304.65M-265.32M
Financing Cash Flow
-135.84M-252.78M-169.37M13.95M-90.14M25.05M

BWX Technologies Technical Analysis

Technical Analysis Sentiment
Positive
Last Price138.07
Price Trends
50DMA
112.32
Positive
100DMA
109.03
Positive
200DMA
112.40
Positive
Market Momentum
MACD
7.23
Negative
RSI
83.21
Negative
STOCH
93.61
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BWXT, the sentiment is Positive. The current price of 138.07 is above the 20-day moving average (MA) of 124.09, above the 50-day MA of 112.32, and above the 200-day MA of 112.40, indicating a bullish trend. The MACD of 7.23 indicates Negative momentum. The RSI at 83.21 is Negative, neither overbought nor oversold. The STOCH value of 93.61 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BWXT.

BWX Technologies Risk Analysis

BWX Technologies disclosed 29 risk factors in its most recent earnings report. BWX Technologies reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

BWX Technologies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (66)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$12.59B43.9028.24%0.72%9.87%14.16%
AIAIR
74
Outperform
$2.48B246.75-1.08%21.07%-120.95%
74
Outperform
$6.33B330.641.45%7.32%
DRDRS
71
Outperform
$12.05B52.849.50%0.79%13.58%25.96%
HIHII
71
Outperform
$8.87B16.3012.27%2.36%-1.04%-21.80%
68
Neutral
$10.29B144.33
16.92%
66
Neutral
$4.51B12.225.40%3.63%4.14%-12.01%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BWXT
BWX Technologies
138.07
47.70
52.78%
AIR
AAR
68.63
1.03
1.52%
HII
Huntington Ingalls
232.73
-3.27
-1.39%
KTOS
Kratos Defense
41.76
22.01
111.44%
DRS
Leonardo Drs
46.07
21.40
86.75%
SARO
StandardAero, Inc.
30.41
-2.56
-7.76%

BWX Technologies Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
BWX Technologies Announces New Interim CFO Appointment
Neutral
May 12, 2025

On May 12, 2025, BWX Technologies announced the resignation of Robb A. LeMasters as CFO, with his decision unrelated to any company disagreements or financial issues. He will remain as a Special Advisor to the CEO until March 2026. Michael T. Fitzgerald, previously Vice President, Finance and Chief Accounting Officer, has been appointed as the interim CFO. Fitzgerald’s appointment is expected to support BWXT’s growth strategy and operational excellence, with his extensive corporate experience and financial understanding ensuring a smooth transition.

The most recent analyst rating on (BWXT) stock is a Buy with a $138.00 price target. To see the full list of analyst forecasts on BWX Technologies stock, see the BWXT Stock Forecast page.

Executive/Board Changes
BWX Technologies Grants CEO $5.5M Stock Incentive
Neutral
May 8, 2025

On May 7, 2025, BWX Technologies‘ Board of Directors approved a special grant of performance restricted stock units and non-qualified performance stock options to CEO Rex D. Geveden, valued at $5.5 million, to incentivize long-term shareholder value creation. The awards, which will vest on December 31, 2027, are contingent on achieving specific revenue, EBITDA margin, and shareholder return targets, reflecting the company’s commitment to aligning executive compensation with performance metrics.

Executive/Board ChangesShareholder MeetingsBusiness Operations and Strategy
BWX Technologies Shareholders Approve Key Governance Measures
Positive
May 7, 2025

At the Annual Meeting on May 2, 2025, BWX Technologies‘ stockholders voted on four key matters. The election of nine directors for a one-year term was approved, along with the advisory vote on executive compensation and the ratification of Deloitte & Touche LLP as the independent auditor. An amendment to limit officer liability under Delaware law also passed, indicating strong shareholder support for the company’s governance and operational strategies.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.